Pfizer Nutrition expands infant feeding options in Nigeria


As part of its response to boost infant nutrition and health in the country, Pfizer Nutrition has opened its new Lagos office to provide wide range of choice of high quality complementary infant nutrition products.

In a chat with BusinessDay during the opening of its nutrition office, Tarek Youssef, Regional President, Africa Middle East, Pfizer revealed that Pfizer Nutrition had developed premium-quality nutrition products scientifically designed to meet the need of infants and lactating mothers.

According to Youssef “These innovative and high quality nutrition products are ideal for mothers who cannot breastfeed and also for those who like to give complementary feeding to their babies, in addition to breast feeding. We want to start a new office in Nigeria because it is the logical thing to do in view of the potential in the market place in exchange of the business model and partnership we have been handling.

Youseff disclosed that following the advent of the opening of the nutrition office, the organization is aimed at bringing to the table the understanding of the needs of the public. He maintained that whenever consumers seek options for breastfeeding, they would find those options at their fingertips and at competitive prices and quality.”

The move, Youseff noted, would advance public understanding of micro nutrient deficiency in the marketplace and what elements that are to be fortified and enriched to meet nutritional needs of the public.
“Our products are registered by NAFDAC and there is a complement of them from Stage I for 0-3 months, Stage II, 6-12 months and Stages 3-4 (above one year) would be available later. We are also promoting breastfeeding because it is the best for babies and also when people understand this, they would understand and appreciate the value of the options that Pfizer Nutrition is providing, in the event that they cannot breast feed. We remain committed towards maintaining the integrity and the high product quality for which Pfizer is known for globally,” Youssef concluded.

Pfizer Nutrition, formerly Wyeth Nutrition is now part of Pfizer Incorporated, the arm that supports the company’s mission to improve health and well being at every stage of life, bringing breadth and depth of consumer and scientific insight to new population in new market around the world.

Notable people during the event include Jide Mike, Director-General, Manufacturers Association of Nigeria (MAN), Adebiyi Olowu, Vice President, Paediatric Association of Nigeria (PAN), Enrico Liggeri, Country Manager, Pfizer Specialties Ltd, Margaret Olele, Associate Director, Communications, Pfizer Specialties, Nigeria and East Africa Region  (NEAR)  to name but a few.
 
 
 

Comments

Post a Comment

Popular posts from this blog

Unilever named most successful brand among FT500

Image
Unilever has been named as the most successful brand among the FT 500 for meeting its philanthropic goals, according to a recent study by Radley Yeldar. Unilever’s sustainability strategy was found to have made the biggest impact of all the companies listed in the FT 500 and the FTSE Eurofirst 100, having achieved the goals set out in its ‘making sustainable life commonplace’ mission statement. Radley Yeldar ranked the British-Dutch multinational consumer goods company number 1 on its Fit for Purpose Index 2015 which assesses and ranks companies based on how they live up to the altruistic promises set out in their brand purpose. The success of Unilever’s Bright Future project was the main driver behind its number 1 ranking. The ongoing initiative is a partnership with the WWF and promotes sustainable manufacturing of its products and a pledge of zero deforestation in doing so. In assessing the strength and impact of Unilever- whose brands include Dove and Dome
Read more

Nigeria now emerging hub for pharma market expansion in Africa

Image
A s growth opportunities continue to move away from traditional pharmaceutical markets and growth patterns in developed markets continue to flatten, many multinational companies (MNCs) like Norvatis, Pfizer, Sanofi, Johnson & Johnson, etc. look toward Africa, including Nigeria for their expanding global footprint. This is evident following GlaxoSmithKline (GSK) plan to invest over $200million in Africa over the next five years, expanding manufacturing in Nigeria and Kenya and building five new factories-Rwanda, Ghana and Ethiopia given its attractive long-term growth potential. With a growing middle class of expected annual disposable income in excess of $1 trillion by 2023, increasing awareness of healthier lifestyles, and a combined Gross Domestic Product (GDP) of $2.9 trillion, rising population growth is emerging as a melting pot for pharmaceutical expansion. Interestingly, of the four MINT countries (Mexico, Indonesia, Nigeria, and Turkey), Nigeria’s
Read more

WHO unveils list of essential diagnostic tests to improve health outcomes

Image
 Today, many people are unable to get tested for diseases because they cannot access diagnostic services. Many are incorrectly diagnosed. As a result, they do not receive the treatment they need and, in some cases, may actually receive the wrong treatment. For example, an estimated 46% of adults with Type 2 diabetes worldwide are undiagnosed, risking serious health complications and higher health costs. Late diagnosis of infectious diseases such as HIV and tuberculosis increases the risk of spread and makes them more difficult to treat. To address this gap, the World Health Organization (WHO) today published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases. “An accurate diagnosis is the first step to getting effective treatment,” says Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “No one should suffer or die because of a lack of diagnostic services, o
Read more